Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
This trial is active, not recruiting.
|Sponsor||National Institute on Drug Abuse (NIDA)|
|Start date||August 2002|
|Trial size||24 participants|
|Trial identifier||NCT00051896, NIDA-CPU-0002-1|
The purpose of this study is to assess the potential interactions between iv cocaine and GBR 12909.
Pharmacokinetic parameter comparison
Male or female participants from 18 years up to 45 years old.
Inclusion Criteria: - Must understand study procedures and provide written informed consent - For additional inclusion criteria information, please contact study site for more information. Exclusion Criteria: - Please contact study site for more information.
|Official title||Double-Blind, Placebo-Controlled, Dose Escalating, Safety and Pharmacology Study With Three Dosages of GBR 12909 in Cocaine Experienced Volunteers|
|Principal investigator||Louis Cantilena, M.D.|
|Description||This is a single dose with escalation, double-blind, placebo-controlled inpatient study in which 24 cocaine experienced volunteers that meet protocol eligibility criteria during a 30 day screen period will be randomized into three dose groups.|
Call for more information